Fundz

Spyre Therapeutics reported raising $180 Million in an initial SEC Form D filing, from an offering of $180 Million

PUBLIC · SYREDec 27, 2023

Amount Raised

$180 Million

$180 Million sold, per SEC Form D (first sale Dec 11, 2023)

Round Type

Venture

WalthamBiotechnologyHealth CareTherapeutics

Quick answer

Spyre Therapeutics raised $180 Million in a funding round, dated December 11, 2023. Spyre Therapeutics is based in Waltham, Massachusetts, United States.

How much did Spyre Therapeutics raise?
Spyre Therapeutics raised $180 Million in a funding round on December 11, 2023.
What does Spyre Therapeutics do?
Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases.
Where is Spyre Therapeutics based and how big is it?
Spyre Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 112 employees.
Who are the decision-makers at Spyre Therapeutics?
Fundz holds 1 contact at Spyre Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Spyre Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Alpha Cognition raised $2.8M (Seed) on January 24, 2024.
  • Calluna Pharma raised $82M (Series A) on January 23, 2024.
  • BridgeBio raised $1.3B on January 22, 2024.
  • Calidi Biotherapeutics raised $10K on January 19, 2024.
  • Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
  • Gallant raised $15M (Series A) on January 8, 2024.

Who to call at Spyre Therapeutics, and when

A new round usually means Spyre Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Spyre Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spyre Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spyre Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spyre Therapeutics

Location

221 Crescent Street

Waltham, Massachusetts, United States

About

Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spyre Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Spyre Therapeutics's next move

See what Strategic adds

Spyre Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.